Back
Tilray Brands Vs. Grace Therapeutics Industry Stock Comparison
Sell
36
TLRY
Tilray Brands
Last Price:
1.73
Seasonality Move:
37.02%
Sell
39
GRCE
Grace Therapeutics
Last Price:
3.08
Seasonality Move:
7.4%
Sell
36
Tilray Brands (TLRY)
is a Sell
Is Tilray Brands a Buy, Sell or Hold?
- The current Tilray Brands [TLRY] share price is $1.73. The Score for TLRY is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- TLRY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Grace Therapeutics (GRCE)
is a Sell
Is Grace Therapeutics a Buy, Sell or Hold?
- The current Grace Therapeutics [GRCE] share price is $3.14. The Score for GRCE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- GRCE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TLRY Stock Price Chart
What is Tilray Brands's stock price today?
-
The Tilray Brands share price today is $1.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TLRY is experiencing slight selling pressure.
GRCE Stock Price Chart
What is Grace Therapeutics's stock price today?
-
The Grace Therapeutics share price today is $3.14
The current trend is moderately bearish and GRCE is experiencing slight buying pressure.
TLRY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 56.1 | Buy |
| Chaikin Money Flow: | -13092959 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.6 - 1.7) | Buy |
| Bollinger Bands (100): | (1.64 - 1.86) | Sell |
GRCE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 49.29 | Sell |
| Chaikin Money Flow: | -25 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.08 - 3.38) | Sell |
| Bollinger Bands (100): | (2.52 - 3.2) | Buy |
TLRY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.68 | Buy |
| 20-day SMA: | 1.64 | Buy |
| 50-day SMA: | 1.69 | Buy |
| 200-day SMA: | 1.84 | Sell |
| 8-day EMA: | 1.68 | Buy |
| 20-day EMA: | 1.67 | Buy |
| 50-day EMA: | 1.7 | Buy |
| 200-day EMA: | 1.86 | Sell |
GRCE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.21 | Sell |
| 20-day SMA: | 3.27 | Sell |
| 50-day SMA: | 2.92 | Buy |
| 200-day SMA: | 2.93 | Buy |
| 8-day EMA: | 3.19 | Sell |
| 20-day EMA: | 3.19 | Sell |
| 50-day EMA: | 3.03 | Buy |
| 200-day EMA: | 2.9 | Buy |
Tilray Brands Earnings Growth & TLRY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.20 per share.
Grace Therapeutics Earnings Growth & GRCE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.16 per share, and a decrease next year of $0.01 per share.
Tilray Brands Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Grace Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||